Singapore’s UltraGreen secures $188M strategic investment led by 65 Equity Partners, Vitruvian Partners
UltraGreen.ai (UltraGreen), a Singapore-based fluorescence-guided surgical technologies and precision healthcare solutions provider, announced Monday the signing of a $188 million strategic investment led by 65 Equity Partners (65EP) and Vitruvian Partners (Vitruvian).
UltraGreen said in a statement that the round also saw participation from August Global Partners (August).
It noted the investment reflects strong confidence in UltraGreen’s artificial intelligence (AI)-powered surgical imaging platform and will support the company’s next phase of growth.
UltraGreen, through its Diagnostic Green business, leads the Fluorescence Guided Surgery (FGS) market as the world’s largest provider of Indocyanine Green (ICG),…
